Wow, VTAE up 80%, also I see that AKBA is up about

Wow, VTAE up 80%, also I see that AKBA is up about 50% on its good trial results.

I am prejudiced but don't you think completion of Phase 1 in a novel first-in-class cancer therapy would be worth more than that percentage up?